The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
Open accessAbstract
A pattern of left ventricular hypertrophy evident on the electrocardiogram is a harbinger of morbidity and mortality from cardiovascular disease. Echocardiography permits the noninvasive determination of left ventricular mass and the examination of its role as a precursor of morbidity and mortality. We examined the relation of left ventricular mass to the incidence of cardiovascular disease, mortality from cardiovascular disease, and mortality from all causes in 3220 subjects enrolled in the Framingham Heart Study who were 40 years of age or older and free of clinically apparent cardiovascular disease, in whom left ventricular mass was determined echocardiographically. During a four-year follow-up period, there were 208 incident cardiovascular events, 37 deaths from cardiovascular disease, and 124 deaths from all causes. Left ventricular mass, determined echocardiographically, was associated with all outcome events. This relation persisted after we adjusted for age, diastolic blood pressure, pulse pressure, treatment for hypertension, cigarette smoking, diabetes, obesity, the ratio of total cholesterol to high-density lipoprotein cholesterol, and electrocardiographic evidence of left ventricular hypertrophy. In men, the risk factor-adjusted relative risk of cardiovascular disease was 1.49 for each increment of 50 g per meter in left ventricular mass corrected for the subject's height (95 percent confidence interval, 1.20 to 1.85); in women, it was 1.57 (95 percent confidence interval, 1.20 to 2.04). Left ventricular mass (corrected for height) was also associated with the incidence of death from cardiovascular disease (relative risk, 1.73 [95 percent confidence interval, 1.19 to 2.52] in men and 2.12 [95 percent confidence interval, 1.28 to 3.49] in women). Left ventricular mass (corrected for height) was associated with death from all causes (relative risk, 1.49 [95 percent confidence interval, 1.14 to 1.94] in men and 2.01 [95 percent confidence interval, 1.44 to 2.81] in women). We conclude that the estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors. An increase in left ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In patients with hypertension, the occurrence of left ventricular hypertrophy (LVH) has been associated with an increase in mortality from all cardiovascular causes (1–4).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [1]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Casale, P. N., Devereux, R. B., Milner, M. R., Zullo, G., Harshfield, G. A., Pickering, T. G., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-173 · Cited by 1,079
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
Levy, D. A., Anderson, K. M., SAVAGE, D. D., Kannel, W. B., Christiansen, J. C., & Castelli, W. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-7 · Cited by 819
Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
Levy, D. A., Savage, D. D., Garrison, R. J., Anderson, K. M., Kannel, W. B., & Castelli, W. P. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91133-7 · Cited by 798
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort
Levy, D. A., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-2-101 · Cited by 700
Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease
Kannel, W. B., Gordon, T., Castelli, W. P., & MARGOLIS, J. R. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-813 · Cited by 638
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy
McLenachan, J. M., Henderson, E., Morris, K. I., & Dargie, H. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171302 · Cited by 576
Research works printed but not linked: 2
- Levy, 1987, Circulation, 76, IV-143
- Marcus, 1987, Circulation, 75, I-19
Cited by
Sorted by citations
Items 701–800 of 1,020
Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage
Niu, P., Shindo, T., Iwata, H., Iimuro, S., Takeda, N., Zhang, Y., Ebihara, A., Suematsu, Y., Kangawa, K., Hirata, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000118466.47982.cc · Cited by 109
Oikarinen, L., Nieminen, M. S., Viitasalo, M. T., Toivonen, L. K., Wachtell, K., Papademetriou, V., Jern, S., Dahlöf, B., Devereux, R. B., & Okin, P. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00025 · Cited by 109
Gardin, J. M., & Lauer, M. S. (2004) · JAMA · doi:10.1001/jama.292.19.2396 · Cited by 109
Feldman, R. D., Campbell, N. R. C., Larochelle, P. M., Bolli, P., Burgess, E. D., Carruthers, S. G., Floras, J. S., Haynes, R. B., Honos, G. N., Leenen, F. H. H., et al. (1999) · PubMed · Cited by 108
Lichtman, J. H., Lorenze, N. P., D’Onofrio, G., Spertus, J. A., Lindau, S. T., Morgan, T. M., Herrin, J. S., Bueno, H., Mattera, J. A., Ridker, P. M., et al. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.928713 · Cited by 108
Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation
Volpe, M., Battistoni, A., Tocci, G., Rosei, E. A., Catapano, A. L., Coppo, R., Prato, S. D., Gentile, S., Mannarino, E., Novo, S., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283525715 · Cited by 108
Prognostic Implications of Left Ventricular Hypertrophy
Stewart, M. H., Lavie, C. J., Shah, S. B., Englert, J. A. R., Gilliland, Y. E., Qamruddin, S., Dinshaw, H. K., Cash, M. E., Ventura, H. O., & Milani, R. V. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.11.002 · Cited by 111
Histone deacetylases in cardiovascular and metabolic diseases
Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 109
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
El‐Gharbawy, A., NADIG, V., Kotchen, J. M., Grim, C. E., Sagar, K. B., Kaldunski, M. L., Hamet, P., Pausová, Z., Gaudet, D., Gossard, F., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.845 · Cited by 108
Independent predictors of isolated clinic (`white-coat') hypertension
Verdecchia, P., Palatini, P., Schillaci, G., Mormino, P., Porcellati, C., & Pessina, A. C. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106000-00004 · Cited by 108
1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH Meeting
&NA;, &. (1989) · Journal of Hypertension · doi:10.1097/00004872-198908000-00014 · Cited by 107
Blood pressure and hypertension in athletes: a systematic review
Berge, H. M., Isern, C. B., & Berge, E. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2014-093976 · Cited by 106
Ou, P., Celermajer, D. S., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., & Mousseaux, É. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.09.008 · Cited by 106
Hinderliter, A. L., Sherwood, A., Gullette, E. C. D., Babyak, M. A., WAUGH, R. A., Georgiades, A., & Blumenthal, J. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1333 · Cited by 106
Measurement of left ventricular mass
Devereux, R. B., Pini, R., Aurigemma, G. P., & Roman, M. J. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715080-00002 · Cited by 106
Birth weight, weight at one year, and left ventricular mass in adult life.
Vijayakumar, M., Fall, C. H., Osmond, C., & Barker, D. J. (1995) · Heart · doi:10.1136/hrt.73.4.363 · Cited by 105
Astrup, A. S., Nielsen, F. S., Rossing, P. R., Ali, S., Kastrup, J., Smidt, U., & Parving, H. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f06428 · Cited by 105
Cardiac Structure and Diastolic Function in Mild Primary Hyperparathyroidism
Walker, M. D., Fleischer, J. B., Tullio, M. R. D., Homma, S., Rundek, T., Stein, E. M., Zhang, C. A., Taggart, T., McMahon, D. J., & Silverberg, S. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2072 · Cited by 106
Longitudinal Determinants of Left Ventricular Mass and Geometry
Gidding, S. S., Liu, K., Colangelo, L. A., Cook, N. L., Goff, D. C., Glasser, S. P., Gardin, J. M., & Lima, J. A. C. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.112.000450 · Cited by 105
Cardiac Disease in Chronic Uremia: Pathophysiology
Amann, K., & Ritz, E. (1997) · Advances in Renal Replacement Therapy · doi:10.1016/s1073-4449(97)70030-x · Cited by 105
Predictors of stroke mortality in elderly people from the general population
Mazza, A., Pessina, A. C., Pavei, A., Scarpa, R., Tikhonoff, V., & Casiglia, E. (2001) · European Journal of Epidemiology · doi:10.1023/a:1021216713504 · Cited by 105
Okere, I. C., Young, M. E., McElfresh, T. A., Chess, D. J., Sharov, V. G., Sabbah, H. N., Hoit, B. D., Ernsberger, P., Chandler, M. P., & Stanley, W. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000248430.26229.0f · Cited by 104
Noninvasive assessment of preclinical atherosclerosis
Lane, H. A., Smith, J. C., & Davies, J. S. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.1.19 · Cited by 104
Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
Hsieh, B. P. C., Pham, M., & Froelicher, V. F. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.041 · Cited by 104
Fang, C. X., Dong, F., Thomas, D. P., Ma, H., He, L., & Ren, J. T. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00319.2008 · Cited by 108
Kane, G. C., Behfar, A., Dyer, R. B., O'Cochlain, D. F., Liu, X., Hodgson, D. M., Reyes, S., Miki, T., Seino, S., & Terzic, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl154 · Cited by 102
Grossman, E., & Messerli, F. H. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.04.006 · Cited by 106
Endurance Training in the Spontaneously Hypertensive Rat
Garciarena, C. D., Pinilla, O. A., Nolly, M. B., Laguens, R. P., Escudero, E. M., Cingolani, H. E., & Ennis, I. L. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.126805 · Cited by 103
de Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103
Rodriguez, C., Diez-Roux, A., Moran, A. E., Jin, Z.-Z., Kronmal, R., Lima, J., Homma, S., Bluemke, D., & Barr, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.046 · Cited by 101
Kawel‐Boehm, N., Kronmal, R. A., Eng, J., Folsom, A. R., Burke, G. L., Carr, J. J., Shea, S., Lima, J. A. C., & Bluemke, D. A. (2019) · Radiology · doi:10.1148/radiol.2019182871 · Cited by 103
Babiker, F. A., Windt, L. J. D., van Eickels, M., Thijssen, V. L., Bronsaer, R., Grohé, C., van Bilsen, M., & Doevendans, P. A. (2004) · Circulation · doi:10.1161/01.cir.0000105682.85732.bd · Cited by 103
Network integration of the adrenergic system in cardiac hypertrophy
Barki‐Harrington, L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.011 · Cited by 104
Botzenhardt, F., Eichinger, W. B., Bleiziffer, S., Guenzinger, R., Wagner, I. M., Bauernschmitt, R., & Lange, R. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.039 · Cited by 103
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
Moody, W. E., Ferro, C. J., Edwards, N. C., Chue, C. D., Lin, E. L. S., Taylor, R. J., Cockwell, P., Steeds, R. P., & Townend, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06608 · Cited by 103
Regulation of Cardiac Remodeling by Nitric Oxide: Focus on Cardiac Myocyte Hypertrophy and Apoptosis
Wollert, K. C., & Drexler, H. (2002) · Heart Failure Reviews · doi:10.1023/a:1020706316429 · Cited by 103
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection
Weeks, K. L., Bernardo, B. C., Ooi, J. Y. Y., Patterson, N. L., & McMullen, J. R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4304-8_12 · Cited by 106
Association of Cardiorespiratory Fitness With Left Ventricular Remodeling and Diastolic Function
Brinker, S., Pandey, A., Ayers, C. R., Barlow, C. E., DeFina, L. F., Willis, B. L., Radford, N. B., Farzaneh‐Far, R., de Lemos, J. A., Drazner, M. H., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.01.004 · Cited by 102
Antihypertensive effect of ACE inhibitory oligopeptides from chicken egg yolks
Yoshii, H., Tachi, N., Ohba, R., Sakamura, O., 武山, 英., & Itani, T. (2001) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/s1532-0456(00)00172-1 · Cited by 102
Mehta, R. H., Bruckman, D., Das, S., Tsai, T., Russman, P. L., Karavite, D., Monaghan, H., Sonnad, S. S., Shea, M. J., Eagle, K. A., et al. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.116558 · Cited by 102
van den Bosch, A. E., Robbers‐Visser, D., Krenning, B. J., McGhie, J. S., Helbing, W. A., Meijboom, F. J., & Roos‐Hesselink, J. W. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.114 · Cited by 102
Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome
Pereira, A. M., Delgado, V., Romijn, J. A., Smit, J. W. A., Bax, J. J., & Feelders, R. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0621 · Cited by 102
Diabetic Cardiomyopathy and Subclinical Cardiovascular Disease
Bertoni, A. G., Goff, D. C., D’Agostino, R. B., Liu, K., Hundley, W. G., Lima, J. A. C., Polak, J. F., Saad, M. F., Szklo, M., Tracy, R. P., et al. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1501 · Cited by 102
Survival advantage of stentless aortic bioprostheses
Westaby, S., Horton, M., Jin, X. Y., Katsumata, T., Ahmed, O., Saito, S., Li, H., & Grunkemeier, G. L. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01736-7 · Cited by 102
Okin, P. M., Roman, M. J., Devereux, R. B., & Kligfield, P. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00421-1 · Cited by 103
Job Status and High-Effort Coping Influence Work Blood Pressure in Women and Blacks
Light, K. C., Brownley, K. A., Turner, J. R., Hinderliter, A. L., Girdler, S. S., Sherwood, A., & Anderson, N. B. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.554 · Cited by 100
Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., & Asada, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.051 · Cited by 102
Cardiac Hypertrophy: Molecular and Cellular Events
Carreño, J. E., Apablaza, F., Ocaranza, M. P., & Jalil, J. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60796-2 · Cited by 101
Woodiwiss, A. J., Molebatsi, N., Maseko, M. J., Libhaber, E. N., Libhaber, C. D., Majane, O. H. I., Paiker, J. E., Dessein, P. H., Brooksbank, R. L., Sareli, P., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328317a78f · Cited by 102
Growth hormone, acromegaly, and heart failure: an intricate triangulation
Saccà, L., Napoli, R., & Cittadini, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01780.x · Cited by 101
Muscle ring finger 1 mediates cardiac atrophy in vivo
Willis, M. S., Rojas, M., Li, L., Selzman, C. H., Tang, R., Stansfield, W. E., Rodriguez, J., Glass, D. J., & Patterson, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00660.2008 · Cited by 100
Fagard, R. H., Pardaens, K., Staessen, J. A., & Thijs, L. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.31 · Cited by 101
Hara, A., Yuhki, K., Fujino, T., Yamada, T., Takayama, K., Kuriyama, S., Takahata, O., Karibe, H., Okada, Y., Xiao, C.-Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.527077 · Cited by 101
Johnson, M. C., Kirkham, F. J., Redline, S. S., ROSEN, C. L., Yan, Y., Roberts, I. A. G., Gruenwald, J., Marek, J., & DeBaun, M. R. (2010) · Blood · doi:10.1182/blood-2009-06-227447 · Cited by 99
Bang, C. N., Devereux, R. B., & Okin, P. M. (2014) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2014.07.003 · Cited by 99
Eng, J., McClelland, R. L., Gomes, A. S., Hundley, W. G., Cheng, S. C., Wu, C. O., Carr, J. J., Shea, S., Bluemke, D. A., & Lima, J. A. C. (2015) · Radiology · doi:10.1148/radiol.2015150982 · Cited by 100
Microalbuminuria and Pulse Pressure in Hypertensive and Atherosclerotic Men
Pedrinelli, R., Dell’Omo, G., Penno, G., Bandinelli, S., BERTINI, A., Bello, V. D., & Mariani, M. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.48 · Cited by 100
Arterial Pulse Wave Dynamics After Percutaneous Aortic Valve Replacement
Davies, J. E., Sen, S., Broyd, C., Hadjiloizou, N., Baksi, J. A., Francis, D. P., Foale, R. A., Parker, K. H., Hughes, A. D., Chukwuemeka, A. O., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.011916 · Cited by 100
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis
Watson, C. J., Horgan, S. J., Neary, R., Glezeva, N., Tea, I., Corrigan, N., McDonald, K., Ledwidge, M. T., & Baugh, J. A. (2015) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248415591698 · Cited by 99
Schlosser, T. W., Mohrs, O. K., Magedanz, A., Voigtländer, T., Schmermund, A., & Barkhausen, J. (2007) · Acta Radiologica · doi:10.1080/02841850601067611 · Cited by 99
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 99
Gender Differences and the Electrocardiogram in Left Ventricular Hypertrophy
Okin, P. M., Roman, M. J., Devereux, R. B., & Kligfield, P. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.242 · Cited by 99
Task force 3. Spectrum of risk factors for coronary heart disease
Pasternak, R. C., Grundy, S. M., Levy, D. A., & Thompson, P. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87731-x · Cited by 99
Left ventricular hypertrophy: An overlooked cardiovascular risk factor
Bauml, M. A., & Underwood, D. A. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77a.09158 · Cited by 98
Farzaneh‐Far, R., Désir, G. V., Na, B., Schiller, N. B., & Whooley, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013496 · Cited by 98
Gerdts, E., Izzo, R., Mancusi, C., Losi, M. A., Manzi, M. V., Canciello, G., LUCA, N. D., Trimarco, B., & SIMONE, G. D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.086 · Cited by 98
Current status of white coat hypertension: where are we?
Nuredini, G., Saunders, A., Rajkumar, C., & Okorie, M. (2020) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944720931637 · Cited by 110
Law, J. P., Pickup, L. C., Pavlović, D., Townend, J., & Ferro, C. J. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00751-4 · Cited by 111
Almqvist, E. G., Bondeson, A., Bondeson, L., Nissborg, A., Smedgård, P., & Svensson, S. (2002) · Surgery · doi:10.1067/msy.2002.128692 · Cited by 98
Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation
Mehta, S. K., Rame, J. E., Khera, A., Murphy, S. A., Canham, R. M., Peshock, R. M., de Lemos, J. A., & Drazner, M. H. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087890 · Cited by 96
Vasan, R. S., Larson, M. G., Aragam, J. R., Wang, T. J., Mitchell, G. F., Kathiresan, S., Newton‐Cheh, C., Vita, J. A., Keyes, M. J., O’Donnell, C. J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s2 · Cited by 98
Cuspidi, C., Meani, S., Negri, F., Giudici, V., Valerio, C., Sala, C., Zanchetti, A., & Mancia, G. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.16 · Cited by 98
Apoptosis signal-regulating kinase 1 as a therapeutic target
Kawarazaki, Y., Ichijo, H., & Naguro, I. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.896903 · Cited by 98
Diabetic cardiomyopathy: Myth or reality?
Ernande, L., & Dérumeaux, G. (2012) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.11.007 · Cited by 97
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
Bazgir, F., Nau, J., Nakhaei‐Rad, S., Amin, E., Wolf, M. J., Saucerman, J. J., Lorenz, K., & Ahmadian, M. R. (2023) · Cells · doi:10.3390/cells12131780 · Cited by 106
Prognostic Significance of Systolic Blood Pressure Increases in Men During Exercise Stress Testing
Prakash, M., Polena, S., Coplan, N. L., Panagopoulos, G., Dhingra, C., MYERS, J. N., & Froelicher, V. F. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.070 · Cited by 97
Aortic Pulse Wave Velocity Is Associated With the Presence and Quantity of Coronary Artery Calcium
Kullo, I. J., Bielak, L. F., Turner, S. T., Sheedy, P. F., & Peyser, P. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000199605.35173.14 · Cited by 97
Chen, L., Jin, Z., Gan, T. X., Chen‐Izu, Y., Hasday, J. D., Karmazyn, M., Balke, C. W., & Scharf, S. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00301.2007 · Cited by 97
Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin
Gyllenborg, J., Rasmussen, S. L., Borch‐Johnsen, K., Heitmann, B. L., K, N. E. S., & Juul, A. (2001) · Metabolism · doi:10.1053/meta.2001.24916 · Cited by 95
Establishment and Performance of a Magnetic Resonance Cardiac Function Clinic
Bellenger, N. G., Francis, J. M., Davies, C., Coats, A. J. S., & Pennell, D. J. (2000) · Journal of Cardiovascular Magnetic Resonance · doi:10.3109/10976640009148669 · Cited by 97
Silberbach, M., Gorenc, T., Hershberger, R. E., Stork, P. A., Steyger, P. S., & Roberts, C. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24858 · Cited by 97
Change in Cardiac Geometry and Function in CKD Children During Strict BP Control
Matteucci, M. C., Chinali, M., Rinelli, G., Wühl, E., Zurowska, A. M., Charbit, M., Pongiglione, G., & Schaefer, F. S. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08420811 · Cited by 96
Quail, M. A., Short, R., Pandya, B., Steeden, J. A., Khushnood, A., Taylor, A. M., Segers, P., & Muthurangu, V. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08763 · Cited by 96
Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy
Zhang, T., Li, S., Bazzano, L., He, J., Whelton, P. K., & Chen, W. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10975 · Cited by 97
Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro
Ocaranza, M. P., Lavandero, S., Jalil, J., Moya, J., Pinto, M., Novoa, U., Apablaza, F., González, L., Hernández, C., Varas‐Godoy, M., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328335d291 · Cited by 96
Body Composition and Prevalence of Left Ventricular Hypertrophy
Kuch, B., Hense, H., Gneiting, B., Döring, A., Muscholl, M. W., Bröckel, U., & Schunkert, H. (2000) · Circulation · doi:10.1161/01.cir.102.4.405 · Cited by 96
Russell, M. W. W., Raeker, M. Ö., Korytkowski, K. A., & Sonnemann, K. J. (2002) · Gene · doi:10.1016/s0378-1119(01)00795-8 · Cited by 96
Epidemiology of Risk Factors for Hypertension
Kornitzer, M., Dramaix, M., & Backer, G. D. (1999) · Drugs · doi:10.2165/00003495-199957050-00003 · Cited by 99
Lonn, E., Shaikholeslami, R., Yi, Q., Bosch, J., Sullivan, B., Tanser, P. H., Magi, A., & Yusuf, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.073 · Cited by 96
Vascular remodeling: The role of angiotensin-converting enzyme inhibitors
Chrysant, S. G. (1998) · American Heart Journal · doi:10.1053/hj.1998.v135.86971 · Cited by 96
Gharavi, A. G., Lipkowitz, M. S., Diamond, J. A., Jhang, J. S., & Phillips, R. A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00198-1 · Cited by 96
Signalling Pathways for Cardiac Hypertrophy
Yamazaki, T., Komuro, I., & Yazaki, Y. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00036-9 · Cited by 96
Yuhki, K., Kojima, F., Kashiwagi, H., Kawabe, J.-I., Fujino, T., Narumiya, S., & Ushikubi, F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.004 · Cited by 97
The Relation of Emergency Duties to Cardiac Death Among US Firefighters
Smith, D. L., Haller, J. M., Korre, M., Sampani, K., Porto, L. G. G., Fehling, P. C., Christophi, C. A., & Kales, S. N. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.11.049 · Cited by 95
Daniels, S. R., Witt, S. A., Glascock, B. J., Khoury, P. R., & Kimball, T. R. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.125851 · Cited by 97
Ghosh, G., De, K., Maity, S., Bandyopadhyay, D., Bhattacharya, S., Reiter, R. J., & Bandyopadhyay, A. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00386.x · Cited by 95
Impact of Prosthesis–Patient Size on Functional Recovery After Aortic Valve Replacement
Koch, C. G., Khandwala, F., Estafanous, F. G., Loop, F. D., & Blackstone, E. H. (2005) · Circulation · doi:10.1161/circulationaha.104.505248 · Cited by 95
Ras Regulates NFAT3 Activity in Cardiac Myocytes
Ichida, M., & Finkel, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004275200 · Cited by 95
Selvetella, G., Notte, A., Maffei, A., Calistri, V., Scamardella, V., Frati, G., Trimarco, B., Colonnese, C., & Lembo, G. (2003) · Stroke · doi:10.1161/01.str.0000078310.98444.1d · Cited by 94
Metadata
- Authors
- Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- National Center for Health Statistics (US)
- Boston University (US)
- ORCID
- Levy, Daniel
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-05-31
- Volume
- 322
- Issue
- 22
- Pages
- 1561-1566
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2334499091
- Cited by
- 5,699
- References
- 28
- Citations by year
- 2026: 77 · 2025: 76 · 2024: 85 · 2023: 100 · 2022: 117 · 2021: 124 · 2020: 156 · 2019: 142 · 2018: 134 · 2017: 170 · 2016: 189 · 2015: 211 · 2014: 215 · 2013: 199 · 2012: 215
- FWCI
- 76.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Keywords
- left ventricular mass, left ventricular hypertrophy, cardiovascular disease incidence, cardiovascular mortality, all-cause mortality, echocardiography, cardiovascular risk factors, hypertension, sex differences, Framingham Heart Study
- MeSH terms
- Blood Pressure, Echocardiography, Female, Follow-Up Studies, Cardiomegaly, Humans, Lipids, Male, Middle Aged, Prognosis, Risk Factors, Smoking, Multivariate Analysis, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
